TAPP Applauds No. Carolina State Treasurer Report Exposing 340B Overcharges

North Carolina State Treasurer Dale R. Folwell, CPA, recently released a report finding that 340B hospitals billed state employees an average price markup of 5.4 times their discounted acquisition costs for oncology drugs. Hospitals generated average spread profits as high as $13,617 per claim on cancer drugs paid for by the North Carolina State Health Plan for Teachers and State Employees.

The Trade Alliance to Promote Prosperity applauds Treasurer Folwell’s efforts to expose 340B program overcharges and abuse. Like Folwell, we are calling on state and federal lawmakers to reform the 340B Drug Pricing Program and to provide hospital price relief to state employees and taxpayers and to keep America globally competitive in the pharmaceutical market and in medical research and development. We also call on state officials in every state to conduct 340B program reviews like the one that was performed in North Carolina in order to shed light on the kinds of 340B program overcharges and abuse that are impeding on America's global competitiveness.

Read the treasurer’s full report here.